LYMESEQ

Serial Number 87144797
602

Registration Progress

Application Filed
Aug 19, 2016
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

LYMESEQ

Basic Information

Serial Number
87144797
Filing Date
August 19, 2016
Abandonment Date
June 5, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jun 30, 2017
Classes
001

Rights Holder

The Translational Genomics Research Institute

03
Address
Suite 600
445 North Fifth Street
Phoenix, AZ 85004

Ownership History

The Translational Genomics Research Institute

Original Applicant
03
Phoenix, AZ

Legal Representation

Attorney
Michael J. Donovan

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Jun 30, 2017 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jun 30, 2017 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Dec 2, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 2, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 2, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 30, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 24, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 23, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Diagnostic reagents for laboratory use, namely, for clinical, medical, or epidemiological laboratory use; chemical preparations for scientific purposes; reagents for use in scientific apparatus for chemical or biological analysis; testing kits containing reagents used in analyzing and detecting certain microorganisms for clinical, medical, or epidemiological laboratory use; microbiological genetic identity tests comprised of reagents for scientific research; biomedical compounds, namely, substrates used in analyzing and detecting certain nucleic acids for laboratory or research use; chemical preparations to be used in biochemical and clinical research; diagnostic preparations for laboratory use in science, namely, for clinical, medical, or epidemiological laboratory use; Medical diagnostic reagents for the analysis of body fluids; microbiological genetic identity tests for medical purposes comprised of reagents; diagnostic preparations for laboratory use, namely, for medical use; clinical medical reagents; diagnostic kits for medical use, comprised of medical diagnostic reagents and assays for testing blood and other body fluids or microbiological specimens; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids or microbiological specimens; medical diagnostic test kits comprised of reagents and assays for testing of body fluids or microbiological specimens; Computer software for healthcare monitoring, namely, monitoring healthcare-acquired infections or community-acquired infections; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for medical monitoring and analysis of medical data; computer software for controlling the operation of medical equipment and test results; computer software for analysis of body fluids; computer software for communication and data transfer between testing facilities and health care professionals; mobile electronic devices, namely, personal digital assistants, tablet computers, mobile phones, laptop computers, and smartphones; laboratory apparatus, for use in medical laboratories, for analysis of body fluids and tissue; Medical and scientific research in the field of microbiological testing and diagnosis and treatment of medical conditions; Development and laboratory testing in the field of microbiological-caused human disease; Scientific research consulting in the field of microbiological-based genetics, genomics, DNA sequencing, and bioinformatics; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Genetic testing for scientific research purposes; Genomic testing for scientific research purposes; Medical and scientific research, development and consulting in the field of infectious diseases; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and next generation sequencing; Medical and scientific research in the field of infectious disease diagnosis epidemiology; Data collection for research purposes, namely, the collection, testing and research of patient specimen molecular and/or genomic data; compiling genomic data for research purposes in the field of medical science; DNA-sequencing for scientific research purposes; Genotyping; Gene screening; consulting services in the field of microbiology; Medical and scientific research services in the field of health care; Scientific research consulting services in the fields of biotechnology, laboratory testing, diagnostics, hospital-acquired and community-acquired infections, and antibiotic-resistant organisms; biological research; biomedical research; laboratory research in the field of microbiology, biochemistry, biology, health and medicine; medical laboratories; medical laboratory services; providing laboratory research services in the field of gene expression, namely, disease biology; scientific laboratory services; Software as a Service (SaaS) for medical and disease analysis; Medical testing for diagnostic or treatment purposes in the field of infectious diseases; Medical diagnostic testing, monitoring and reporting services; Medical evaluation services, namely, for evaluation of presence of infectious diseases; Medical monitoring services; Medical diagnostic, prognostic and theranostic screening and testing, namely, determination of antibiotic resistance of microorganisms; Collection and preservation of DNA for medical and research purposes; Consulting services in the nature of providing medical information; Consulting services in the field of healthcare, insurance reimbursement, and microbiology; Genetic testing for scientific diagnostic purposes; Genomic testing for scientific diagnostic purposes; Genotype-based testing for medical purposes; Providing information in the field of infectious disease prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; Microbiological screening for medical diagnostic purposes; Medical care consulting services in the fields of biotechnology, laboratory testing, diagnostics, hospital-acquired and community-acquired infections, and antibiotic-resistant organisms; Consulting services in the nature of providing information about medical services; Consulting services in the field of insurance reimbursement; consulting services in the nature of providing information about insurance reimbursement; Consulting services in the field of medical education, namely, providing education and training information relating to the identification, diagnosis and treatment of medical conditions, including healthcare-acquired infections or community-acquired infections; Education services, namely, providing live and on-line continuing professional education seminars in the medical, scientific and insurance field; educational services, namely, seminars and educational conventions
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001